Forthcoming events in 2021
April 13th, 2021, 10:10 – 11:30 am Pacific Coast Time (6:10 -7:30 pm GMT). I will be giving a talk as part of the Medical Cultures Lab, a scholarly network of the University of California, San Francisco, with title “Mobilization of expert knowledge and advice for the management of the COVID-19 pandemic in Italy”.
Join Zoom here
March 30th, 2021, 5:30 pm BST (British Standard Time). I will be delivering the 2021 Baron de Lancey Lecture at the University of Cambridge (UK), with title: “Law, Hormones, and Sport: a level playing field?”. Registration is open for this event here:
February 23rd, 2021. Institute of Advanced Studies, University of Bologna. “The legacy of Caster Semenya: Unfair Advantages, Equality of Opportunity and the Construction of Categories in Sport”
The recording of the seminar is available here:https://www.youtube.com/watch?v=thIB4u3K_EM&list=PLaUmBQ7P5K-CW0SfRVs1lYh5yZUheaiOR&index=22
January 15th, 2021. I spoke at the IME Virtual Conference: Ethics lessons from a pandemic. on the topic of ethics of accelerated drug development.
Here is the recording of my session: https://youtu.be/zeGq1SjYzkA
- December 14th, 2020What can bioethics and bioethicists do for humanity and society in the pandemic? what should be the criteria for access to life saving resources in a context of scarcity? what are the ethically justifiable trade-offs in lockdown policies? To these and other questions will answer Silvia Camporesi, member of IFOM alumni Network, during the second IFOM Alumni Talk. https://lnkd.in/dhjH8-b
- On July 22nd, 2020 I spoke in a King’s Expert Series webinar on the topic ‘Climate change and covid-19: What have we learnt?’ https://www.kcl.ac.uk/events/climate-change-and-covid-19-what-have-we-learned
- On May 14th and 18th, 2020, I lectured for the MAISI programme in Leuven.
- On May 5th: I gave a guest lecture at the Institute of Advanced Studies, University of Bologna, with title: ‘Bioethics as a profession in the time of covid-19’: http://www.isa.unibo.it/en/events/5-may-bioethics-as-a-profession-in-the-time-of-covid-19-lecture-by-silvia-camporesi-associate-professor-kings-college-london-uk
- Sunday November 3rd, 2019 at 4 pm, I participated in a debate at Battle of Ideas titled “Caster Semenya, running into controversy: genes, gender and sport“
- On October 10th, 2019 I participated in a debate with Julian Savulescu on ‘Doping in sport’ for the MSc in Practical Ethics at the University of Oxford.
- In April I presented a paper at the British Philosophy of Sport Annual Conference (Oxford April 2nd-5th) titled “Unfair advantages in sport: What sort of evidence should the Court of Arbitration for Sport consider in relation to the ‘Semenya, ASA and IAAF’ case?”
- MaiSi Erasmus Mundus Programme MA Prague March 27-29th, 2019. I taught four sessions for the students of the Sports Ethics & Integrity MA funded by the European Union on the topic of ‘unfair advantages: testosterone, assistive technology, and race in sport’. Great cohort, fantastic discussions! thanks to Professors Jim Parry and Irena Martinkova for inviting me.
- September 27- 28, 2018: I moderated a roundtable on ethical applications of CRISPR genome editing technologies for the 17th CRG Symposium in Barcelona, Spain. Details of the roundtable and symposium can be found here: http://www.crg.eu/en/event/17th-crg-symposium-trends-biology-cutting-edge-techniques-genomes-organisms
- June 5th, 2018, FAIRNESS IN SPORTS AND GAMES WORKSHOP, King’s College London. Title: “When is it fair to be a woman athlete? Considerations regarding the eligibility of female athletes with hyperandrogenism to compete in the female category”. You can access slides SCamporesi Fairness Hyperandrogenism 05.06.18
- June 11th-12th 2018, Health & Biofutures workshop at Monash University, Prato Campus. Title: “Genome Editing, Pigoons and the Future of Organ Transplants”. You can access slides Silvia_ Biofutures Workshop_11.06.18
- May 16-19, 2018, American Society for Gene and Cell Therapy Annual Conference,Chicago (IL), USA. Wednesday May 16th “Bioethics of Genome Editing”, 1:30 – 3:00 pm. You can watch the official ASGCT recording of the event here: https://www.youtube.com/watch?v=UMnE8XzbBWQ
- April 12-14, 2018, Swansea (UK), British Philosophy of Sport Annual Conference, “The re-inscription of the concept of biological race through sport in society: A conceptual analysis”
I gave two seminar at the Maine Medical Center Research Institute in August.
In the first one, on August 21st (10 am to 12 pm), I discussed the emerging ethical issues of CRISPR genome editing technology.
In case you missed it and are curious, here’s the PDF presentation.Camporesi CRISPR Embryo Research_MMRCI 08.21.17
In the second one, on August 28th (5:30 -6:30 pm), I talked about “Gene Enhancement and Gene Doping: The Next Big Threat to the Spirit of Sport?”
In case you missed it and are curious, here’s the PDF presentation Silvia Gene Enhancement MMC 08 28 17
On May 4, 2017 I spoke at the Sport Resolutions Annual Conference taking place in London on May 4th on hyperandrogenism, ethics and athletics.
On April 5th, 2017, I spoke at the Oxford Mt Sinai Consortium on April 5th, 2017. The title of my talk is “Investigating Public Trust in Expert Knowledge: Narrative, Ethics, and Engagement”. You can access the full programme of the conference here: Oxford Mt Sinai Consortium Programme 2017.
February 27, 2017:
On February 27th I gave a talk (in Italian) at the Fondazione Bassetti in Milano on the topic of “Investigating Public Trust in Expert Knowledge: Narrative, Ethics and Engagement”.
For Italian-speaking: il mio intervento su “Fiducia pubblica nei saperi esperti in medicina e tecnoscienza” tenuto alla Fondazione Basssetti a Milano il 28 febbraio 2017 e’ online: la registrazione dell’incontro (intervento, piu’ domande), comprese le slides e il testo dell’intervento:
Un sentito ringraziamento a Angela Simone, Tommaso Correale, Anna Pellizzone, Francesco Samore’ e il Presidente Piero Bassetti per avermi ospitata!
February 8th, 2017: launch of Journal of Bioethical Inquiry Investigating Public Trust in Expert Knowledge Symposium at King’s College London.
On October 27th I gave a plenary session on the ethical issues of CRISPR genome editing: human and non-human applications at the CRISPR-based genome engineering training day held at VIB in Leuven on October 27th, 2016. You can access the pdf of my talk here:
and the paper on which it is based here:
On October 6-9th I attended the annual meeting of the American Society for Bioethics and Humanities in Washington D.C., where I represented King’s Bioethics & Society MA Programme that I direct, and I chaired a panel presenting the forthcoming special issue of Journal Bioethical Inquiry on “Investigating public trust in expert knowledge: narrative, ethics and engagement“ (March, 2017). I also gave a paper on Non-Invasive Prenatal Testing. For more info on the panel and forthcoming of the special issue:
I chaired the Bioethics panel at the Gap Summit (Global Biotech Revolution) in Cambridge UK, April 4-6th, 2016. Here is the full recording of the bioethics panel discussion:
and here is my interview, where I answer the question: “Which debates do you think will be most important in biotechnology and bioethics by 2050?”
In late April 2016 I gave a few invited talks on CRISPR genome editing in the Bay Area.
On April 26th , I gave an invited talk at the Center for Law & Biosciences at Stanford University, where I discussed the ethical and political relevance of the somatic/germ-line distinction in the CRISPR genome editing debate. On April 27th I gave a talk titled “ “CRISPR/Cas9 Genome editing: Bioethics and Biopolitics in the UK and US” as part of the Culpeper Seminar Series at the Department of Anthropology, History and Social Medicine at UCSF, where she was formerly a visiting research fellow. I was also interviewed by Professor of Social Medicine at UCSF, about her book “From Bench to Bedside, to Track and Field: The Context of Enhancement and its Ethical Relevance”, published for UC Medical Humanities Press. In the interview I discuss how genome editing technologies to alter the human embryo and to select children’s traits, genetic technologies to enhance athletic performance, and doping in professional sport. The podcast of the interview is available here:
To conclude my visit to the Bay Area I gave a talk the Markkula Centre for Applied Ethics, at Santa Clara University. The podcast of the talk and the slides are available here: https://www.scu.edu/ethics/all-about-ethics/the-ethics-of-crisprcas9-genome-editing/
October 19th, 2015, Department of Philosophy Birmingham University, Invited Seminar : “A call for creativity in the CRISPR/Cas9 genome editing debate”
November 18th, 2015, Department of Science & Technology Studies, University College London, Invited Seminar “The emergence of socio-technical imaginaries in the CRISPR/Cas9 debate”
October 1st 2015, Institute of Biomedical Ethics, Basel University (Switzerland), Invited Seminar: Genome Editing, Bioethics Policy and Politics in the US and the UK.
June 18, 2015 2nd IME Research Conference, Newcastle University. I will be one of the panelists (Dr Lucy Frith, Dr Zoe Fritz, Dr Jon Ives) discussing interdisciplinary approach to Bioethics
June 13, 2015. Delighted I will be one of the speakers at Critical Voices 2015, Trinity Theatre, Tunbridge Wells.
February 4, 2015 SSHM Seminar Series. “Stop this talk of new eugenics! Reframing the discourse surrounding reproductive genetic technologies”. The recording of this talk is available here.
January 19, 2015: MY BOOK LAUNCH! SW1.17, East Wing, Somerset House.
With Professor Brian Hurwitz and Professor Soren Holm.
October 16-19, 2014: 16th Annual Meeting American Society for Bioethics & the Humanities, San Diego “Speaking of… eligogenics, or genetic technologies applied for selective reproduction”.
September 4, 2014: Leeds Metropolitan University “Sporting Females: Past, Present and Future, “Unfair advantage and the myth of the level playing field in athletic competition”.
April 8, 2014: Oxford-Mt Sinai Bioethics Consortium: “Performance enhancement, elite athletes and anti-doping governance: Towards a shared participatory responsibility for doping“.